Bidirectional relationship of diabetic retinopathy with anxiety and depression: a meta-analysis - Scorecard - MDSpire

Bidirectional relationship of diabetic retinopathy with anxiety and depression: a meta-analysis

  • By

  • Seng Fan

  • Ziyue Gai

  • Hui Ma

  • Ziye Wen

  • Chunlei Ma

  • Dongying Fan

  • Songying Qian

  • Zengxin Li

  • April 13, 2026

  • 0 min

Share

Clinical Scorecard: The Interconnectedness of Diabetic Retinopathy with Anxiety and Depression: A Meta-Analytical Review

At a Glance

CategoryDetail
ConditionDiabetic retinopathy (DR) and its bidirectional relationship with anxiety and depression
Key MechanismsMicrovascular damage in DR leads to vision impairment; psychological distress (anxiety and depression) may worsen DR outcomes and vice versa
Target PopulationPatients with diabetes mellitus suffering from diabetic retinopathy
Care SettingClinical settings managing diabetes and diabetic retinopathy, including ophthalmology and mental health services

Key Highlights

  • Meta-analysis of 34 studies involving 383,195 patients showed a significant bidirectional positive correlation between DR and depression.
  • DR is significantly correlated with anxiety, with an odds ratio of 2.23 (95% CI: 1.07-4.68).
  • Personalized psychological care is recommended during DR treatment to address anxiety and depression.

Guideline-Based Recommendations

Diagnosis

  • Screen patients with diabetic retinopathy for symptoms of anxiety and depression due to their high prevalence.
  • Use observational study data to assess the presence of DR in patients presenting with anxiety or depression.

Management

  • Incorporate personalized psychological care alongside standard DR treatments such as laser photocoagulation, anti-VEGF injections, corticosteroids, and vitrectomy.
  • Address mental health to potentially improve glycemic control, treatment compliance, and quality of life.

Monitoring & Follow-up

  • Long-term monitoring of psychological status in patients with DR is essential due to the chronic nature of the disease and its treatments.
  • Regular assessment of vision and mental health to detect progression or worsening of DR and psychological symptoms.

Risks

  • Anxiety and depression may exacerbate poor glycemic control and reduce treatment adherence, increasing the risk of DR progression.
  • Vision loss from DR can contribute to worsening psychological distress, creating a vicious cycle.

Patient & Prescribing Data

Patients with diabetes mellitus diagnosed with diabetic retinopathy and comorbid anxiety or depression

Psychological interventions should be integrated with ophthalmologic treatments to improve overall outcomes; addressing mental health may reduce DR progression risk.

Clinical Best Practices

  • Conduct comprehensive assessments for anxiety and depression in patients with diabetic retinopathy.
  • Implement multidisciplinary care involving ophthalmologists, endocrinologists, and mental health professionals.
  • Educate patients about the bidirectional relationship between DR and psychological health to encourage adherence and self-care.
  • Use evidence-based psychological therapies tailored to individual patient needs during DR management.

References

Original Source(s)

Related Content